Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Sees Significant Increase in Short Interest

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totaling 35,280 shares, a growth of 99.8% from the June 15th total of 17,654 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 103,592 shares, the short-interest ratio is currently 0.3 days.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Otsuka presently has an average rating of “Hold”.

Get Otsuka alerts:

Check Out Our Latest Report on OTSKY

Otsuka Stock Performance

Shares of OTSKY stock traded up $0.08 on Friday, hitting $34.01. The company’s stock had a trading volume of 16,308 shares, compared to its average volume of 40,092. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. The company has a market capitalization of $36.53 billion and a PE ratio of 14.35. The stock’s 50 day moving average is $34.45 and its 200-day moving average is $33.11. Otsuka has a fifty-two week low of $21.68 and a fifty-two week high of $37.52.

Otsuka (OTCMKTS:OTSKY – Get Free Report) last released its earnings results on Tuesday, April 28th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.16. The firm had revenue of $3.96 billion for the quarter, compared to analysts’ expectations of $3.78 billion. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. Equities research analysts expect that Otsuka will post 1.98 earnings per share for the current fiscal year.

Otsuka Company Profile

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

Featured Stories

• Five stocks we like better than Otsuka
• AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
• Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
• TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
• GE Aerospace Faces a Prove-It Moment in Q2 Earnings

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.